John F. Crowley - 12 Jan 2022 Form 4 Insider Report for Entrada Therapeutics, Inc. (TRDA)

Role
Director
Signature
/s/ Jared Cohen, as Attorney-in-Fact
Issuer symbol
TRDA
Transactions as of
12 Jan 2022
Net transactions value
+$48,575
Form type
4
Filing time
13 Jan 2022, 18:53:53 UTC
Previous filing
07 Jan 2022
Next filing
19 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TRDA Common Stock Purchase $48,575 +5,000 $9.72 5,000 12 Jan 2022 Direct
holding TRDA Common Stock 32,864 12 Jan 2022 See footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of (i) 19,171 shares of common stock and (ii) 13,693 shares of restricted common stock issued upon early exercise of stock options held by John F. Crowley 2021 Family Trust. John F. Crowley exercises voting and dispositive power over the shares beneficially owned by John F. Crowley 2021 Family Trust.